Jose Aguilera
Barcelona, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Correction to: C-terminal Domain of the Heavy Chain of Tetanus Toxin Ameliorate Lipopolysaccharide Induced Hemiparkinsonism in Rats.
Journal: Neurotoxicity research
Published: July 29, 2026
Recombinant Hc-TeTx modulates TrkA-related signaling and preserves cholinergic integrity in the nucleus basalis magnocellularis after Aβ(25-35) injury.
Journal: Neuroscience
Published: April 09, 2026
Peroxisome Proliferator-Activated Receptors (PPARs) May Mediate the Neuroactive Effects of Probiotic Metabolites: An In Silico Approach.
Journal: International journal of molecular sciences
Published: January 15, 2025
Intrapallidal injection of cannabidiol or a selective GPR55 antagonist decreases motor asymmetry and improves fine motor skills in hemiparkinsonian rats.
Journal: Frontiers in pharmacology
Published: May 17, 2022
The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson's disease.
Journal: Neuroscience research
Published: May 18, 2021
Interaction between a Novel Oligopeptide Fragment of the Human Neurotrophin Receptor TrkB Ectodomain D5 and the C-Terminal Fragment of Tetanus Neurotoxin.
Journal: Molecules (Basel, Switzerland)
Published: April 13, 2021
The C-terminal fragment of the heavy chain of the tetanus toxin (Hc-TeTx) improves motor activity and neuronal morphology in the limbic system of aged mice.
Journal: Synapse (New York, N.Y.)
Published: June 16, 2020
Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model.
Journal: Toxins
Published: March 25, 2020
Antidepressant effects of C-Terminal domain of the heavy chain of tetanus toxin in a rat model of depression.
Journal: Behavioural brain research
Published: March 16, 2019
Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease.
Journal: Neurotoxicity research
Published: June 22, 2018
Last Updated: 09/26/2026